Disorder No More

Researchers hunt for biomarkers of Asperger's syndrome, a condition that officially no longer exists.

Written byKerry Grens
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

SCALP SENSOR: A study that delivered magnetic pulses to the scalps of children with autism and Asperger’s found differences in motor cortical inhibition.JEROME MALLER

Patients with Asperger’s syndrome (AS) display a distinctive suite of characteristics: high intelligence, high functioning, social impairments, and odd speech, movements, and interests. Earlier this year, after countless documented cases since the 1940s, Asperger’s disappeared as an official diagnosis, at least according to the latest version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) used by clinicians. With the elimination of the label, researchers who have studied Asperger’s are now left in the lurch. “They’re trying to research a group that technically doesn’t exist anymore,” says Peter Enticott, an autism researcher at Monash University in Melbourne, Australia. “That’s a bit frustrating.”

Many in the Asperger’s community were not happy with the changes. Not only might people lose part of how they identify themselves, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies